November 8, 2019
At MetroHealth Medical Center, Christopher Hall offers patients struggling with addiction something unique: common ground.
October 14, 2019
Johnson & Johnson Settles Ohio Opioid Cases for $20.4 Million to Avoid Federal Trial Does this mean anything for the pharmaceutical giant's long-term outlook?
Johnson & Johnson (NYSE:JNJ) made news in late August when a state judge in Oklahoma found the pharmaceutical giant guilty of deceptively marketing its opioid medications to customers. The verdict was seen as a hallmark ruling for the pharmaceutical sector. That, combined with Purdue Pharma declaring bankruptcy due to the $12 billion settlement it's facing, has many investors worried the door has been opened to similar, perhaps much larger, fines for other companies in the opioid market.
October 1, 2019
(Reuters) - Johnson & Johnson said on Tuesday it will pay $20.4 million to settle claims by two Ohio counties, allowing the U.S. healthcare giant to avoid an upcoming federal trial seeking to hold the industry responsible for the nation’s opioid epidemic.
August 26, 2019
Oklahoma pursued the first case against a drug manufacturer for the national public health disaster, and the ruling may point to what lies ahead in 2,000 more lawsuits.
August 20, 2019
As a landmark trial over the opioid crisis grows closer, Endo International (ENDP) agreed to a $10 million settlement with two Ohio counties that claimed the drug maker contributed to the problem by inappropriately marketing its addictive painkillers.
August 12, 2019
Ohio Attorney General Dave Yost said he wants "a good settlement for Ohio", but the state is still preparing to move forward with civil cases against drug companies. His comments came Monday as he addressed the opioid epidemic that has ravaged the state.
July 16, 2019
Billions in federal grants for treatment and prevention programs are set to end next year. The Trump administration has not said whether it will seek to extend them.
March 26, 2019
Federal money to fight the opioid crisis nearly doubled in the last two years, according to a national think tank’s new report analyzing that funding.